- Home
- ELPC vs QGEN Comparison
ELPC vs QGEN Comparison
Compare ELPC & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELPC | QGEN |
|---|---|---|
| Founded | 1954 | 1986 |
| Country | Brazil | Netherlands |
| Employees | 4276 | 5500 |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.5B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ELPC | QGEN |
|---|---|---|
| Price | $11.76 | $41.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $45.76 |
| AVG Volume (30 Days) | 356.1K | ★ 2.7M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | 5.53% | ★ 7.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | $12.11 | $5.71 |
| P/E Ratio | $77.44 | ★ $24.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.94 | $32.53 |
| 52 Week High | $13.70 | $57.82 |
Technical Indicators
Market Signals| Indicator | ELPC | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 56.97 |
| Support Level | $11.33 | $39.08 |
| Resistance Level | $11.83 | $42.33 |
| Average True Range (ATR) | 0.23 | 0.82 |
| MACD | 0.01 | -0.10 |
| Stochastic Oscillator | 68.98 | 63.73 |
Price Performance
Historical ComparisonAbout ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power Sale, Services, and Holding. The majority of its revenue is generated from the Power distribution segment under which it provides public electricity distribution services, being responsible for the operation and maintenance of the distribution infrastructure, as well as providing related services.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).